UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2014, Second edition., ISBN 9781783264216, xii, 338 pages
Book
American journal of obstetrics and gynecology, ISSN 0002-9378, 2016, Volume 215, Issue 1, pp. S1 - S46
Obstetrics and Gynecology | placenta | therapeutics | drugs | trial | pregnancy | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Biomarkers - metabolism | Placenta - immunology | Placenta Diseases - genetics | United States | Humans | Translational Medical Research | Placenta - embryology | Rats | Genetic Markers | National Institute of Child Health and Human Development (U.S.) | Molecular Targeted Therapy | Drug Discovery | Placenta Diseases - physiopathology | Drug Delivery Systems | Placenta - metabolism | Pregnancy | Placenta - physiopathology | Animals | Placenta Diseases - drug therapy | Female | Models, Animal | Mice | Placenta Diseases - metabolism | Pregnancy Outcome | Pregnant women | Health aspects | Children | Index Medicus | Abridged Index Medicus | trials
Journal Article
The lancet oncology, ISSN 1470-2045, 2009, Volume 10, Issue 5, pp. 459 - 466
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Prognosis | Follow-Up Studies | Dacarbazine - therapeutic use | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Glioblastoma - radiotherapy | Brain Neoplasms - metabolism | DNA Methylation | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Female | Glioblastoma - metabolism | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Promoter Regions, Genetic | Survival Rate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | DNA Modification Methylases - genetics | Survival Analysis | Glioblastoma - drug therapy | Glioblastoma - mortality | Antimitotic agents | Medical colleges | Care and treatment | Oncology, Experimental | Analysis | Clinical trials | Research | Radiotherapy | Antineoplastic agents | Glioblastoma multiforme | Cancer | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, pp. S8 - S8
Internal Medicine | Protection and preservation | Developing countries | Global temperature changes | Fishing | Environmental economics | Environmental health | Marine resources conservation | Analysis | Protected areas | Climate | Populations | Logit models | Climatic data | Human influences | Childrens health | Conservation | Economic factors | Social factors | Marine conservation | Biodiversity | Developing countries--LDCs | Coastal ecosystems | Incidence | Degradation | Demographics | Children | Biodegradation | Coasts | Marine protected areas | Oceans | Health risks | Socio-economic aspects | Fisheries | Environmental factors | Resource exploitation | Anthropogenic factors | Children & youth | Climate change | Overfishing | Marine ecosystems | Models | Economic impact | Information theory
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9856, pp. 1819 - 1828
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Neurology | Organic mental disorders. Neuropsychology | General aspects | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Biological and medical sciences | Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis | Medical sciences | Interferon-beta - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Recurrence | Adjuvants, Immunologic - administration & dosage | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Administration, Cutaneous | Alemtuzumab | Adjuvants, Immunologic - adverse effects | Young Adult | Disease-Free Survival | Antibodies, Monoclonal, Humanized - administration & dosage | Interferon beta-1a | Interferon-beta - adverse effects | Adolescent | Adult | Female | Infusions, Intravenous | Complications and side effects | Multiple sclerosis | Dosage and administration | Research | Drug therapy | Fees & charges | Biomedical research | Lymphocytes | Compensation | Interferon | Pharmaceutical industry | Index Medicus | Abridged Index Medicus
Journal Article